HealthDay (10/29) reports, “Maternal use of valproic acid, but not lamotrigine, is associated with an increased risk for autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder” (AD/HD) “among children,” investigators concluded after using “Swedish-registry data to examine the risks for ASD and” AD/HD “in 14,614 children born from 1996 to 2011 to women with epilepsy.” Researchers then examined “maternal-reported first-trimester use of any antiseizure medications and the three most commonly reported individual” medicines “(valproic acid, lamotrigine, and carbamazepine).” The findings were published online Oct. 28 in the journal Neurology.
Related Links:
— “Maternal Use of Valproic Acid Linked to ASD, ADHD in Offspring, HealthDay, October 29, 2020